Applied DNA Sciences (APDN) Misses Q1 EPS by 10c

Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.30), $0.10 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.56 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Morgan Stanley more than doubles Lenovo price target on AI-driven growth
• JPMorgan Upgrades Largan Precision Co Ltd. (3008:TT) to Overweight